Related references
Note: Only part of the references are listed.mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
Yilei Zhang et al.
NATURE COMMUNICATIONS (2021)
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Xuefei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
Sanne C. F. A. Huijberts et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo
Shunnan Yao et al.
CANCER LETTERS (2020)
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Bowen Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
Ji-Ning Jia et al.
FRONTIERS IN PHARMACOLOGY (2020)
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
Xiang Song et al.
FRONTIERS IN ONCOLOGY (2020)
Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
Alessandro Russo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Role of GPX4 in ferroptosis and its pharmacological implication
Tobias M. Seibt et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells
Tao Bai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Gloria E. Villalpando-Rodriguez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
J. Remon et al.
ANNALS OF ONCOLOGY (2018)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Anti-tumor effects of Atractylenolide I on bladder cancer cells
Rui Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway
Emily N. Reinke et al.
PLOS ONE (2014)
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Sylvia S. Gayle et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Share Paper
